Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
Clinical Study on Triple Negative Breast Cancer With Chinese Medicine
ClinicalTrials.gov study NCT03332368. IPD Sharing: NO. Countries: 1. Publications: 1.
Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03358017. IPD Sharing: NO. Countries: 1. Publications: 15.
A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT03145961. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT03109080. IPD Sharing: YES. Countries: 1. Publications: 2.
Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01560663. IPD Sharing: Not stated. Countries: 1. Publications: 4.
MicroRNA Profiles in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04771871. IPD Sharing: YES. Countries: 1. Publications: 4.
Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03243838. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cisplatin + RT for Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01674842. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ipatasertib Plus Non-Taxane Chemotherapy for Advanced or Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT04464174. IPD Sharing: NO. Countries: 2. Publications: 1.
Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer
ClinicalTrials.gov study NCT05872412. IPD Sharing: NO. Countries: 1. Publications: 10.
Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT00707707. IPD Sharing: Not stated. Countries: 4. Publications: 1.
EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients
ClinicalTrials.gov study NCT00448305. IPD Sharing: Not stated. Countries: 6. Publications: 1.
A Study of KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT03872791. IPD Sharing: YES. Countries: 1. Publications: 0.
Study on Androgen Receptor and Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03383679. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative
ClinicalTrials.gov study NCT02276443. IPD Sharing: Not stated. Countries: 1. Publications: 8.
Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01898117. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients
ClinicalTrials.gov study NCT06225284. IPD Sharing: NO. Countries: 1. Publications: 27.
A Phase 2 Study of Standard Chemotherapy Plus BSI-201 (a PARP Inhibitor) in the Neoadjuvant Treatment of Triple Negative Breast Cancer
ClinicalTrials.gov study NCT00813956. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial)
ClinicalTrials.gov study NCT02441933. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT06027268. IPD Sharing: NO. Countries: 1. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.